Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.300
0.00 (0.00%)
Sep 24, 2026, 4:17 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 69.92 million as of September 24, 2026. Its market cap has decreased by -11.20% in one year.
Market Cap
69.92M
Enterprise Value
55.24M
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.30
ChartMarket Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 69.92M, a decrease of -71.58%. That is a compound annual growth rate of -23.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 69.92M | 100.00% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.03B |
| Dicot Pharma AB | 780.46M |
| EQL Pharma AB | 685.09M |
| Cinclus Pharma Holding AB | 547.28M |
| Moberg Pharma AB | 504.83M |
| Orexo AB | 440.01M |
| Enzymatica AB | 411.44M |
| Klaria Pharma Holding AB (publ.) | 145.62M |